Inhibition of cholinergic potentiation of insulin secretion from pancreatic islets by chronic elevation of glucose and fatty acids: Protection by casein kinase 2 inhibitor

OBJECTIVES: Chronic hyperlipidemia and hyperglycemia are characteristic features of type 2 diabetes (T2DM) that are thought to cause or contribute to β-cell dysfunction by “glucolipotoxicity.” Previously we have shown that acute treatment of pancreatic islets with fatty acids (FA) decreases acetylch...

Descripción completa

Detalles Bibliográficos
Autores principales: Doliba, Nicolai M., Liu, Qin, Li, Changhong, Chen, Pan, Liu, Chengyang, Naji, Ali, Matschinsky, Franz M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641685/
https://www.ncbi.nlm.nih.gov/pubmed/29031723
http://dx.doi.org/10.1016/j.molmet.2017.07.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641685/
https://www.ncbi.nlm.nih.gov/pubmed/29031723
http://dx.doi.org/10.1016/j.molmet.2017.07.017

Ejemplares similares